# Flavopiridol Plus Cisplatin or Carboplatin in Treating Patients With Advanced Solid Tumors

> **NCT00003690** · PHASE1 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 48 (estimated)

## Conditions studied

- Breast Cancer
- Melanoma (Skin)
- Prostate Cancer
- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** alvocidib
- **DRUG:** carboplatin
- **DRUG:** cisplatin

## Key facts

- **NCT ID:** NCT00003690
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-12
- **Primary completion:** 2003-09
- **Final completion:** 2003-09
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2011-08-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003690

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003690, "Flavopiridol Plus Cisplatin or Carboplatin in Treating Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00003690. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*